Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2005 1
2006 2
2007 1
2008 7
2010 1
2011 1
2012 3
2013 3
2014 6
2015 3
2016 11
2017 10
2018 7
2019 3
2020 5
2021 6
2022 5
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

73 results

Results by year

Filters applied: . Clear all
Page 1
Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer.
von Minckwitz G, Procter M, de Azambuja E, Zardavas D, Benyunes M, Viale G, Suter T, Arahmani A, Rouchet N, Clark E, Knott A, Lang I, Levy C, Yardley DA, Bines J, Gelber RD, Piccart M, Baselga J; APHINITY Steering Committee and Investigators. von Minckwitz G, et al. N Engl J Med. 2017 Jul 13;377(2):122-131. doi: 10.1056/NEJMoa1703643. Epub 2017 Jun 5. N Engl J Med. 2017. PMID: 28581356 Free PMC article. Clinical Trial.
Breast cancer treatment: A phased approach to implementation.
Mutebi M, Anderson BO, Duggan C, Adebamowo C, Agarwal G, Ali Z, Bird P, Bourque JM, DeBoer R, Gebrim LH, Masetti R, Masood S, Menon M, Nakigudde G, Ng'ang'a A, Niyonzima N, Rositch AF, Unger-Saldaña K, Villarreal-Garza C, Dvaladze A, El Saghir NS, Gralow JR, Eniu A. Mutebi M, et al. Among authors: eniu a. Cancer. 2020 May 15;126 Suppl 10:2365-2378. doi: 10.1002/cncr.32910. Cancer. 2020. PMID: 32348571 Free article. Review.
The global burden of women's cancers: a grand challenge in global health.
Ginsburg O, Bray F, Coleman MP, Vanderpuye V, Eniu A, Kotha SR, Sarker M, Huong TT, Allemani C, Dvaladze A, Gralow J, Yeates K, Taylor C, Oomman N, Krishnan S, Sullivan R, Kombe D, Blas MM, Parham G, Kassami N, Conteh L. Ginsburg O, et al. Among authors: eniu a. Lancet. 2017 Feb 25;389(10071):847-860. doi: 10.1016/S0140-6736(16)31392-7. Epub 2016 Nov 1. Lancet. 2017. PMID: 27814965 Free PMC article. Review.
Long-term efficacy analysis of the randomised, phase II TRYPHAENA cardiac safety study: Evaluating pertuzumab and trastuzumab plus standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer.
Schneeweiss A, Chia S, Hickish T, Harvey V, Eniu A, Waldron-Lynch M, Eng-Wong J, Kirk S, Cortés J. Schneeweiss A, et al. Among authors: eniu a. Eur J Cancer. 2018 Jan;89:27-35. doi: 10.1016/j.ejca.2017.10.021. Epub 2017 Dec 8. Eur J Cancer. 2018. PMID: 29223479 Clinical Trial.
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial.
Martin M, Holmes FA, Ejlertsen B, Delaloge S, Moy B, Iwata H, von Minckwitz G, Chia SKL, Mansi J, Barrios CH, Gnant M, Tomašević Z, Denduluri N, Šeparović R, Gokmen E, Bashford A, Ruiz Borrego M, Kim SB, Jakobsen EH, Ciceniene A, Inoue K, Overkamp F, Heijns JB, Armstrong AC, Link JS, Joy AA, Bryce R, Wong A, Moran S, Yao B, Xu F, Auerbach A, Buyse M, Chan A; ExteNET Study Group. Martin M, et al. Lancet Oncol. 2017 Dec;18(12):1688-1700. doi: 10.1016/S1470-2045(17)30717-9. Epub 2017 Nov 13. Lancet Oncol. 2017. PMID: 29146401 Clinical Trial.
Enhancing global access to cancer medicines.
Cortes J, Perez-García JM, Llombart-Cussac A, Curigliano G, El Saghir NS, Cardoso F, Barrios CH, Wagle S, Roman J, Harbeck N, Eniu A, Kaufman PA, Tabernero J, García-Estévez L, Schmid P, Arribas J. Cortes J, et al. Among authors: eniu a. CA Cancer J Clin. 2020 Mar;70(2):105-124. doi: 10.3322/caac.21597. Epub 2020 Feb 18. CA Cancer J Clin. 2020. PMID: 32068901 Free article. Review.
Live European School of Oncology e-Sessions (e-ESO).
Siano M, Marangoni F, Pavlidis N, Peccatori FA, Aapro M, Eniu A, Rolfo C, Cavalli F, Costa A. Siano M, et al. Among authors: eniu a. Crit Rev Oncol Hematol. 2021 Jul;163:103301. doi: 10.1016/j.critrevonc.2021.103301. Epub 2021 Mar 16. Crit Rev Oncol Hematol. 2021. PMID: 33741505 Review.
Extended Adjuvant Chemotherapy in Triple-Negative Breast Cancer.
Locatelli MA, Curigliano G, Eniu A. Locatelli MA, et al. Among authors: eniu a. Breast Care (Basel). 2017 Jul;12(3):152-158. doi: 10.1159/000478087. Epub 2017 Jun 27. Breast Care (Basel). 2017. PMID: 28785182 Free PMC article. Review.
Expert Discussion: ASCO 2021.
Paluch-Shimon S, Gelmon KA, Eniu A, Gligorov J. Paluch-Shimon S, et al. Among authors: eniu a. Breast Care (Basel). 2021 Aug;16(4):429-432. doi: 10.1159/000518369. Epub 2021 Jul 23. Breast Care (Basel). 2021. PMID: 34602951 Free PMC article. No abstract available.
ESO's career development program (2002-2021): Presentation and evaluation.
Pavlidis N, Peccatori FA, Eniu A, Rassy E, Aapro M, Rolfo C, Cavalli F, Costa A. Pavlidis N, et al. Among authors: eniu a. Crit Rev Oncol Hematol. 2022 Jan;169:103576. doi: 10.1016/j.critrevonc.2021.103576. Epub 2021 Dec 30. Crit Rev Oncol Hematol. 2022. PMID: 34974091 Review.
73 results